Leadership Team

The Leadership Team at Endeavor Biomedicines drives strategic direction and oversight for the company’s clinical-stage initiatives, focusing on the development of innovative therapies for Idiopathic Pulmonary Fibrosis. This team, composed of co-founders and executives with expertise in regulatory affairs, chemistry, manufacturing, and controls (CMC), collaboratively guides the company's research, ensures compliance with industry regulations, and facilitates effective communication with stakeholders to advance the Hedgehog inhibitor program.